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We  present  a  method  for  high-throughput  alternative  splicing  detection  in  expressed
sequence  data.    This  method  effectively  copes  with  many  of  the  problems  inherent  in
making inferences  about splicing and alternative splicing on the basis of  EST  sequences,
which in addition to being fragmentary and full of sequencing errors, may also be chimeric,
mis-oriented, or contaminated with genomic sequence.   Our method, which relies both on
the Partial Order Alignment (POA) program for constructing multiple sequence  alignments,
and its Heaviest Bundling function for generating consensus sequences,  accounts  for  the
real  complexity of expressed  sequence  data by  building  and  analyzing  a  single  multiple
sequence alignment containing all of the expressed sequences in a particular cluster aligned
to genomic sequence.  We  illustrate application of this method to human UniGene Cluster
Hs.1162, which contains expressed sequences from the human HLA-DMB gene.  We  have
used this method to  generate  databases,  published  elsewhere,  of  splices  and  alternative
splicing relationships for the human, mouse and rat genomes.  We  present  statistics  from
these calculations, as well as the CPU time for running our method on expressed  sequence
clusters of varying size, to verify that it truly scales to complete genomes.
1  Introduction
Alternative splicing describes the process by which multiple exons can be  spliced
together  to  produce  different  mRNA  isoforms,  encoding  structurally  and
functionally  distinct  protein  products.
1,2    Recent  studies  have  indicated  that  the
mechanism of  alternative  splicing  not  only  plays  a  large  role in  expanding  the
repertoire of gene function during the lifetime of an organism, but  also  facilitates
the  evolution  of  novel  functions  in  alternatively  spliced  exons,  which  are  less
subject to the effects of natural selection.
3  Alternative splicing appears increasingly
to make an important contribution to the complexity of the higher eukaryotes, by
multiplying  the  number of  gene  products  possible  from  the  baseline  number of
genes.    This  issue  has  received  much  attention  since the  human  genome  (once
estimated to contain up to 120,000 genes
4) was reported to contain  only  ~32,000
genes.
5,6    Large-scale  expressed  sequence  tag  (EST)  and  mRNA  sequencing  has
made  possible  multiple  bioinformatics  studies  of  alternative  splicing.
5,7-11    In
contrast with previous expectations that alternative splicing plays a relatively minor
role in functional regulation (affecting perhaps 5 – 15% of genes), these EST-based
studies have reported that alternative splicing is ubiquitous, observed in 40 – 60%
of human genes.While these results have aroused increasing interest in alternative splicing, there
are many unanswered questions for the next phase of research.  First of  all,  these
studies were very different in their detailed methodology and results.  For example,
these methods  divide  into  two  very  different  camps.    Some  methods  directly
compare expressed sequences (ESTs and mRNA) to each other to identify divergent
forms  (insertions  and  deletions),  which  are  interpreted  as  alternative  splicing.
8,12
Other  methods  compare  the  expressed  sequences  individually  to  the  genomic
sequence to identify divergent patterns of exon inclusion.
7,10  These two approaches,
which we will refer to as “EST Comparison” and “Genomic Mapping”, cause very
different patterns of false positive and false negative errors, and neither approach is
by  itself  ideal.    Second,  EST-based  alternative  splice  detection  faces  many
fundamental technical challenges, concerning the experimental data, bioinformatics
methods, and biological interpretation.
13  Thus, it is now essential to assess the key
technical factors that determine the reliability of such alternative splicing analyses.
14
In this paper we present a detailed examination of the technical problems we have
encountered in undertaking high-throughput analyses of alternative splicing over the
last four years, and the specific solutions we have developed for these problems, in
seeking to minimize both false positive and false negative errors.
2  Methods
2.1  Overview
In  theory,  detection  of  alternative  splicing  is  straightforward:  comparison  of
expressed sequences from a given  gene  can  identify  insertions  and  deletions  that
indicate alternative exon usage.  In practice, however, this apparently simple task is
complicated  by  serious  technical  problems  that  can  produce  artifacts  resembling
alternative  splicing.    The subtlety  of  these challenges  is  well  illustrated  by  the
question of whether to use EST Comparison vs. Genomic Mapping.  As we  will
show in our analysis below, EST Comparison is vulnerable  to  a  wide  variety  of
problems (paralog mixing and genomic contamination, to name a  few)  that  cause
false positive errors (alternative splice predictions that are not reliable).  However,
this does not necessarily mean that Genomic Mapping is preferable.    As  we  will
show, Genomic Mapping not only raises many problems of computational load but
also of accuracy, including significant false negatives.    Thus,  we  have  concluded
that neither method is adequate by itself, and our approach combines both methods
in an unusual hybrid approach.
A flow chart detailing our alternative splicing analysis is shown in Figure  1.
Our  analysis  takes as  input  a  single  UniGene  EST  cluster
15  that  contains  both
mRNA and EST sequences from a particular organism along with  the  organism’s
complete genome  sequence.    Our  analysis  produces  as  output  a  mapping  of  the
cluster  onto  genomic  sequence,  a  multiple  sequence  alignment  of  the  set  of
expressed sequences aligned both to each other and to the genomic sequence, a set
of detected splices stored as pairs of indices in the genomic sequence, and a set of
alternative splicing relationship stored as pairs of indices of splice sites.   Figure 1.  Flow-chart depicting our alternative splicing detection method.
Nodes are labeled with the input/output of each step in the method.  Edges are labeled with the process
undertaken at each step in the method.
2.2  Mapping the cluster of expressed sequences to genomic sequence
Extensive analysis of EST  alignments  has  demonstrated  that  they  are  a  valuable
source of polymorphism identification, including SNPs and alternative splicing.
7,16
However, we have found that such analysis is very vulnerable to artifacts  in  both
the experimental methods and the bioinformatics interpretation.
17  Since alternative
splicing  is  identified  in  these alignments  as  large  insertions  and  deletions,  any
artifact that gives rise to such differences in ESTs will cause false positives that can
be difficult to screen out.
13  We have identified a number of such causes of artifacts.
First,  genomic  contamination  (EST  library  clones  derived  from  genomic  DNA
rather than mRNA) and incomplete mRNA processing (clones derived from mRNA
molecules whose splicing has not been completed) will produce the appearance  of
large  insertions,  due  to  retention  of  some  intron  sequences.    Second,  paralog
contamination (mixing of ESTs derived from different, paralogous genes as a single
EST  cluster)  can  also  produce  the  artifactual  appearance  of  alternative  splicing,
which actually reflects differences between paralogous genes.  Third, the EST data
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genomic sequenceare frequently massive and complex.  For example, a UniGene cluster for a single
gene  can  contain  up  to  5000  ESTs,  far  too  large  for  most  multiple  sequence
alignment programs to compare.
Genomic mapping provides an obvious solution to many of these problems, by
permitting  easy  recognition  of  genomic  contamination  /  intron  retention,  and
verification of which gene a given EST is from.
7,10,13  When the complete genome
sequence  is  available,  it  enables  one  to  check  definitively  for  the  presence  of
possible paralogs, and to require that each EST match perfectly to  its  target  gene
(allowing for sequencing error) as a condition for inclusion in our calculation.
11  
On the other hand,  attempting  to  map  EST  sequences  directly to  the  entire
genome  itself  poses  serious  problems.    Because  ESTs  are  short  single-pass
fragments and full of sequencing errors, BLASTing them individually against  the
genome sequence is both computationally expensive (e.g. for the human genome, 4
million ESTs vs. 3 billion bases of genomic sequence) and error prone, leading to a
high false negative rate for splicing and alternative splicing detection.  Matching a
short, error-filled EST fragment against short genomic exons  (150  nt  on  average,
but can be as short as 10 nt) separated by large introns (from 1 kb up to >20kb) is
very  challenging,  and  both  standard  search  programs  (such  as  BLAST
18)  and
multiple  sequence  alignment  programs  (such  as  CLUSTAL
19)  cannot  guarantee
reliable results.
To solve these problems, our method constructs a multiple sequence alignment
(MSA) for the cluster of ESTs,  extracts  one  or  more “consensus”  sequences  that
represent the aligned  ESTs,  and  maps  these consensus  sequences  to  the  genome
using  BLAST.    The  BLAST  mapping  step  is  straightforward,  and  has  been
described in detail.
11  However, the  MSA  and  consensus  construction  steps  pose
significant new  challenges.    First,  the  large  number of  expressed  sequences  that
must be aligned (up to 5000 ESTs in a single UniGene cluster) exceed the time and
memory  limitations  of  most  MSA  software.
12    To  solve  this  problem,  we  use
Partial  Order  Alignment  (POA),  whose  time  and  memory  requirements  grow
linearly with the number and length of EST sequences to be aligned.
20  POA  can
align 5,000 EST sequences in approximately 4 h on an inexpensive Pentium II PC.
More importantly, POA generates the EST alignment as a  graph  structure  that  is
able to represent both regions of match and regions of divergence: in regions where
an  EST  matches  other ESTs,  it  follows  their  path  in  the  alignment  graph;  in
regions where it diverges, it produces a new branch in the alignment graph.    The
alignment  graph  can  accurately  represent  any  level  of  complexity  in  the  input
sequence data: while a simple dataset of EST fragments of a single mRNA isoform
would  produce  a  single,  linear  path,  a  set  containing  a  mix  of  ESTs  from
paralogous genes, genomic contaminants, or chimeric sequences would result in  a
branched alignment structure that reflects this complexity.  
Moreover, this approach provides a natural, robust way  for  dealing  with  this
complexity  so  that  it  does  not  cause  artifacts  in  alternative  splice  detection.
Specifically,  we  generate  consensus  sequence(s)  by  analyzing  the  Partial  Order
Multiple Sequence Alignment (PO-MSA) using the paralog separation algorithm of
the Heaviest Bundling function of the POA program.
17  This method finds multipleconsensus  paths  through  the  PO-MSA  graph,  and  then  associates  with  each
consensus  path  all  of  the  expressed  sequences  which  follow  that  path  (with  an
allowance  for  sequencing  error).
17    By  separating  ESTs  that  show  signs  of
substantial divergence from the majority, POA’s consensus generation is insulated
from artifacts due to paralog mixing, genomic contamination, etc.
Ordinarily,  Genomic  Mapping  confronts  the  twin  difficulties  of  poor
sensitivity and enormous inefficiency due to the high levels of sequencing error and
redundancy in ESTs.  Mapping individual ESTs is both harder (due to their short
size and poor sequence quality) and very time consuming.  We resolve both these
issues by using the consensus sequences  obtained  from  Partial  Order  Alignment.
This both converts the EST data to reliable, assembled consensus sequence (greatly
increasing sensitivity and robustness), and drastically reduces the number of search
steps that must be performed.  For large EST clusters (>100 ESTs) we have found
this reduces the number of BLAST searches by 20 to 100-fold.  In order to map the
UniGene cluster to genomic sequence, we select the consensus sequence  to  which
the majority of the expressed sequences have been bundled, since it  most  closely
approximates a full-length mRNA transcript.  The remaining consensus sequences,
to which have been bundled the paralogous ESTs, chimeric ESTs, and mis-oriented
ESTs that are not 90% identical to the majority consensus sequence, summarize the
experimental and bioinformatics artifacts in the data.  
To assess the value of  using  POA  and  Heaviest  Bundling  to  cope  with  the
complexity of the UniGene expressed sequence data, we have constructed the  PO-
MSAs  of  80,000  Human  UniGene  clusters  using  POA,  and  run  the  Heaviest
Bundling function to extract the minimum number of  linear  consensus  sequences
required  to  describe  the  aligned  EST  sequences  to  at  least  90%  identity.    The
number of consensus sequences generated by Heaviest Bundling is a useful measure
of  the  degree  of  complexity  of  the  data.    For  all  Human  UniGene  clusters
containing  at  least  10  ESTs,  we  counted  the  number  of  consensus  sequences
generated by Heaviest  Bundling.    Remarkably,  a  single  consensus  sequence  was
generated for only 16% of  the  Human  UniGene  clusters;  two  or  three  consensus
sequences were generated for 41% of the clusters; four to ten consensus sequences
were generated for 43% of the clusters.  These data suggest that the large insertions
and  deletions  in  multiple  sequence  alignments  of  expressed  sequence  clusters,
which  result  from  experimental  and  bioinformatics  errors,  are  not  a  minor
phenomenon in the UniGene data, but are instead the norm.  Their prevalence in the
UniGene data necessitates the  application  of  POA  and  Heaviest  Bundling  to  the
problem of mapping a UniGene cluster to genomic sequence.Figure 2.  POA facilitates accurate alignment of EST fragments to genomic sequence.
In this figure, all alignments are  represented  as PO-MSAs, regardless  of the manner  in  which  they
were  constructed.  The nodes in the PO-MSA  are  represented  as  squares  and  directed  edges  are
shown only at branch points; nodes containing genomic sequence are white with grey nodes indicating
exons, while nodes containing the EST sequence  are  always colored  red.  In  A,  the  EST  fragment
cannot pay the gap penalty in order to align its last six nucleotides to exon 3, instead the six nucleotides
are not aligned to genomic sequence at all (*) and so they do not provide evidence  for the splicing of
intron 2.  In B, the EST fragment aligns to the PO-MSA containing multiple ESTs and mRNAs aligned
to  genomic  sequence  along  the  edge  connecting  exons  2  and  3.    In  this  case,  aligning  the  six
nucleotides to exon 3 (**) does not require the payment of a large gap penalty and so the EST provides
evidence for the splicing of intron 2.
2.3  Aligning expressed sequences to genomic sequence and to each other
Once a genomic location for an EST cluster has been identified, the method must
next compare each EST to the genomic sequence to identify alternative exon usage.
Once again, this apparently simple task is undercut by many technical difficulties.
Whereas  gene  mapping  only  requires  finding  the  right  genomic  region,  reliable
splice detection requires an exact, robust  alignment  of  each  EST  to  the  genomic
sequence.    This  is  much  harder  to  ensure.    Whereas  EST  Comparison  based
methods rely on multiple sequence alignment,  Genomic  Mapping  based  methods
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Brely on  pairwise  alignment,  i.e.  aligning  each  individual  EST  to  the  genomic
sequence.    While  pairwise  alignments  between  full-length  mRNA  and  genomic
sequence are likely to be reliable, pair-wise alignments between EST fragments and
genomic sequence are much more difficult to construct accurately, because ESTs are
short, randomly fragmented, and full of sequencing errors.  Figure 2A shows a pair-
wise sequence alignment between an EST fragment and genomic sequence.      The
six nucleotides at the end of the EST  fragment,  which  should  align  to  the  third
exon in the genomic sequence, fail to do so because the score for perfectly matching
them to genomic sequence is insufficient to compensate for the  large  gap  penalty
required to accommodate the large intron between exons 2 and 3.  Instead, these six
residues do not align to genomic sequence at all.  Any attempt to detect splices on
the basis of the resulting pair-wise alignment alone would fail to identify the splice
that removes the second intron, resulting in a false negative.  
Partial Order Alignment provides a systematic solution to this  problem.    As
long as the PO-MSA contains at least one EST aligned across the gap, aligning a
new EST can follow this path without any gap penalty.  In this case, even the short
EST fragment will align correctly across the gap from exon 2 to exon 3 (see Figure
2B).  
The  key  difference  here  is  that  POA  provides  a  hybrid  method  between
conventional EST Comparison  and  Genomic  Mapping:  each  EST  is  aligned  not
only against the genomic sequence, but also against the set of all previous ESTs at
the same time, to identify the best scoring alignment path.  In practice,  we  align
full-length  mRNA  sequences  to  genomic  sequence  first,  and  then  align  EST
sequences to the growing PO-MSA in order of decreasing length.  This ensures that
the evidence for splices, for which any sequence observation is able to pay the gap
penalty, may be augmented by fragmentary sequence observations.  In this way, our
method is able to not only accurately align all EST fragments to genomic sequence,
but also to combine the evidence for splicing from multiple ESTs.  
This is valuable not only to rescue many EST splice observations that would
normally be lost, but also to detect when several ESTs show a similar divergence
from  the  genomic  sequence  (for  example,  indicating  that  they  may  actually  be
derived from a paralogous gene).  These ESTs would be aligned to each other as a
distinct path in the alignment, branching away from the genomic sequence.   This
information is then used to filter the  set  of  ESTs  that  are  retained  for  analyzing
splicing.  The detailed retention criteria have been previously described.
11
2.4  Splicing and alternative splicing detection in PO-MSAs
Figure 3B shows the PO-MSA of all of the expressed sequences in human UniGene
cluster Hs.1162 aligned to genomic sequence.   Once the PO-MSA is constructed
detecting splices amounts to finding large deletions in expressed sequences relative
to genomic sequence.  These deletions manifest themselves as directed edges in theFigure 3.  Splicing and alternative splicing detection in a human expressed sequence cluster.
Figure A shows the PO-MSA of a single expressed sequence aligned to genomic sequence.  The nodes
in the PO-MSA are  represented  as squares and the directed  edges are  shown only at branch  points;
nodes containing genomic sequence are white, while nodes containing the expressed sequence are red.
Figure B shows the PO-MSA graph, constructed by POA, of the ESTs and mRNAs in UniGene cluster
Hs.1162 aligned to genomic sequence.  In this visualization, rendered  by the Partial Order  Alignment
Visualizer (POAVIZ),
16 nodes are  red dots, directed  edges are  dotted blue lines, aligned nodes  are
adjacent  to  each  other  and  genomic  sequence  is  shown  as  a  black  line.    Nodes  and  edges
corresponding to insertions relative to genomic sequence are shown above the genomic sequence,  and
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Dappear  as blue spikes topped with red dots,  while  the  edges  corresponding  to  deletions  relative  to
genomic sequence  are  shown below, and  appear  solely  as  blue  spikes.  The  number  of  expressed
sequences aligned to a particular position in the genomic sequence  is reflected  in the thickness of red
dots along the black line representing the genomic sequence  so that the regions of genomic sequence
corresponding to exons appear  as red rectangles  above the black line.  The edges corresponding to
splices are  in bold, while edges corresponding to alternative splices are  shown in  green.    Figure  C
shows the splicing graph constructed from the PO-MSA shown in B.  Nodes correspond to exons, while
edges correspond  to splices.  Figure D shows  the  graphical  representation,  provided  by  the  ASAP
database,
14 of the splicing and alternative splicing of the HLA-DMB gene inferred from the expressed
sequences in human UniGene cluster Hs.1162 using our method.  The four mRNA isoforms inferred
from this data are shown as well.
alignment  graph  between  a  node  containing  genomic  nucleotide  i  and  a  node
containing genomic nucleotide i+x, where x is greater than 10 (Figure 3A).  While
one might be tempted to find these edges by depth first or breadth first search, the
easiest way to find all of the large deletions in the expressed sequences relative to
genomic sequence is  to  extract  from  the  PO-MSA  the  set  of  pair-wise  sequence
alignments  between  each  of  them  and  genomic  sequence  and  then  analyze  them
directly.  In order to verify each splice once it has been detected, we check not only
the number of expressed sequences indicating the existence of the splice, but  also
whether  the  splice  has  valid  intronic  splice  site  sequences  (GT  /  AG).    Next,
verified  splices,  which  are  stored  as  pairs  of  indices  in  genomic  sequences,  are
compared  to  each  other in  order  to  infer  alternative  splice  relationships.    If  the
genomic sequence delimited by two of pairs of splices overlap, we identify the pairs
as having an alternative splice relationship (Figure 4).  
                           
Figure 4:  Filtering of alternative splicing by splice pair overlap relationships.
In all four diagrams, genomic sequence  is shown as a straight black line, and splices are  shown  as
dotted black lines.  The 5’ splice sites and 3’ splice sites are  labeled for the  splice  depicted  above
genomic sequence.   The ASAP database  reports alternative splice relationship types 1 and 2, which
produce alternative 3’ splicing, alternative 5’ splicing, and exon skipping.
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3 4In  order  to  filter  out  alternative  splice  relationships  that  are  the  result  of
genomic  contamination,  we  identify  only  those  alternative  splicing  relationships
between mutually exclusive splices, i.e. pairs of splices whose 5’ splice sites or 3’
splice sites are the same, as valid. These valid alternative splice relationships are the
basis  on  which  we  make  inferences  about  alternative  5’  splicing,  alternative  3’
splicing, and exon skipping.  Figure 3B shows the  eight  splices  and  eight  valid
alternative splicing relationships detected in human UniGene cluster Hs.1162 using
this method.
3  Results
We have applied our method to genome-wide detection of splicing and alternative
splicing in the human, mouse, and rat genomes.  This procedure is fully automated,
can be applied to any genome, and its computation  time  scales  linearly with  the
amount of EST data (Figure 5).  
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Figure 5: Total computation time as a function of increasing EST data.
For each  number of sequences  in  the  range  of  50  to  1200,  the  cpu  time  was  computed  for  five
sequence clusters containing roughly the same number of expresses  sequences.   The black line plots
the  average  of  these  five  cpu  times  versus  the  number  of  sequences.    These  calculations  were
performed in an 1.4 GHz AMD Athlon running Linux.
Our method mapped 17,656 multi-exon genes to exact locations in the human
genome (January 2003 data), 14,556 multi-exon genes in mouse, and 8,342 multi-
exon genes in rat.  In the human data, it detected over 35,000 alternative splicing
relationships, more than doubling the number of predicted gene products versus the
number  expected  from  the  estimated  32,000  human  genes  without  alternative
splicing.    We  detected  a  total  of  115,518  splices  and  35,433  alternative  splice
relationships,  of  these  30,891  were  novel  and  12,615  were  novel  and  weresupported  by  multiple  expressed  sequences.  Using  the  January  2002  mouse
UniGene  data  we  detected  91,225  splices  and  12,528  alternative  splice
relationships, of these 11,687 were novel and 4,090 were novel and were supported
by multiple expressed sequence observations. Using the January 2002 rat UniGene
data we detected 31,177 and 1,143 alternative splice relationships, of these 11,687
were  novel  and  4,090  were  novel  and  were  supported  by  multiple  expressed
sequence observations.
Table 1: Total alternative splice detection in three genome-wide analyses.
Total Human 1/02 Mouse 1/02 Rat 1/02 Human 1/03
Clusters 96109 85049 61582 111064
Clusters with a consensus sequence 96040 83876 56668 110927
Clusters mapped to genome 68011 54115 39588 64577
Splices detected 133369/ 18173 91225/ 14556 31177/8342 115518/17656
Alternative splice relationships  30793/7991 12528/4895 1143/680 35433/7834
Alternative splice relationships
with multiple evidence 14656/5205 4931/2488 468/274 17157/5307
Novel alternative splice relationships 26504/7393 11687/4691 919/581 30891/7313
Novel alternative splice relationships
with multiple evidence 10367/4094 4090/2178 244/169 12615/4310
N.B. ratios are  the number of splices of a particular  type divided by the total number of clusters  in
which they occur.
4  Discussion and conclusions
We have presented a method for genome-wide detection of splicing and alternative
splicing using expressed sequence data.  We  have  demonstrated  that  this  method
can be run on a genome-wide scale, both by running it on the full human, mouse
and rat genomes, and by assessing the cpu time required to run it on clusters with
number of sequences ranging from 50 to 1200.  We  have  also  provided evidence
that  the  partial order  alignment  algorithms  are  useful  for  coping  with  the  true
complexity  of  expressed  sequence  data,  screening  out  experimental  and
bioinformatics artifacts in EST data that might cause  spurious  alternative  splices.
In  addition,  we  have  argued  for  the  value  of  POA  for  simultaneously  aligning
expressed sequences to each other and to genomic sequence in order to  effectively
cope with EST fragmentation, which contributes to the loss of evidence for splicing
and alternative splicing when short ESTs cannot be accurately aligned to genomic
sequence.  
While we have briefly explained the process by which we detect splicing  and
alternative splicing in the PO-MSA of all of the expressed sequences  in  a  clusteraligned to genomic sequence, we have not discussed the benefits of this approach.
One of the major advantages of  the  PO-MSA  representation  is  that  its  structure,
which reflects exons,  introns,  and  splices,  can  be  easily  abstracted  as  a  splicing
graph
21 (see  Figure  3C).    We  have  been  able  to  exploit  this  feature  in  order  to
design algorithms for inferring full-length  mRNAs  isoforms  either  from  the  PO-
MSA of the expressed sequences directly,
17 or from the splicing graph inferred from
the PO-MSA of the expressed sequences aligned to genomic sequence.
22  The other
major advantage of the PO-MSA representation is that it stores all of the evidence
for a particular splice or alternative splice in a single data structure.  This could be
useful  for  calculating  statistics  measuring  the  evidence  for  a  particular  splice  or
alternative splice  relationship  from  multiple  EST  and  mRNA  observations.    By
applying such methods, we would be able to associate lod scores  with  all  of  the
splices  and  alternative  splicing  relationships  in  our  datasets.    These  lod  scores
would be very useful for molecular  biologists  as  they  determine  the  direction of
their expensive and time consuming  experimental  work  in  the  area  of  alternative
splicing.
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